# Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

> **NCT04626583** · PHASE1 · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 8 (actual)

## Conditions studied

- Mesenchymal Stromal Cells
- Cornea
- Safety
- Corneal Defect

## Interventions

- **BIOLOGICAL:** Allogeneic MSC

## Key facts

- **NCT ID:** NCT04626583
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-04-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04626583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04626583, "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04626583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*